K864442

Substantially Equivalent

NORFLOXACIN SUSCEPTIBILITY POWDER

Applicant: Merck, Sharp & Dohme
Product code: JTT
Advisory panel: Microbiology
Date received: 1986-11-12
Decision date: 1986-12-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: West Point, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.